News
XPose Therapeutics embarks on the discovery and development of novel oncology medicines targeting DNA Damage Response with non-dilutive funding from NCI
XPose Therapeutics is leveraging 3D structures of molecular fragments bound to drug targets to develop specific therapeutics.
Biotech Startup Discovers Novel Hand Sanitizer for COVID-19, Offering Long-lasting 4+ Hours of Protection
IonLAST™, a novel hand sanitizer, kills germs on contact and, unlike common hand sanitizers, provides protection against their transmission for more than four hours after applying to skin.
With $30M and Stanford immunotherapy pioneer, biotech eyes one of the toughest brain diseases
A Stanford University spinout is joining the small army of biotech companies trying to find drugs for amyotrophic lateral sclerosis (ALS).
Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases
Tranquis Therapeutics are committed to the discovery and development of innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases.
Biotech startup announces R&D collaboration with major Japanese drug delivery company
The companies will evaluate novel formulations of drugs that have been notoriously difficult to formulate and deliver into the skin.
BioWorld: Drug developers’ Golden Ticket
BioWorld: Drug developers’ Golden Ticket, worth a lot more than a tour of a candy manufacturing plant
Nitrome Biosciences Raises $38M Series A Financing
Read online article at BUSINESS WIRE San Francisco, Calif., April 21, 2020 /BUSINESS WI [...]
Life Science Entrepreneurs Moving Into New Biotech Incubator
Home to 19 entrepreneurs already, up to 50 companies expected soon.
Third MBC BioLab Opens in Bay Area
Home to 19 entrepreneurs already, up to 50 companies expected soon.
CellFE Raises $3.6M in Seed Round
Read online article at YAHOO finance SAN CARLOS, Calif., Jan. 16, 2020 /PRNewswire/ -- [...]
Mammoth Biosciences Raises $45 Million For Crispr Diagnostics
And Its Tech Is Already Being Used Against Coronavirus Mammoth Biosciences is a MBC B [...]
How a biotech incubator is helping Big Pharma punch ‘golden tickets’ for startups
By Ron Leuty – Staff Reporter, San Francisco Business Times Dec 9, 2019, 2:16pm PS [...]
LogicInk appears on “The World According to Jeff Goldblum”, new series on Disney+
MBC BioLabs resident company, LogicInk, appeared on the Disney+ streaming platform, [...]
Co-founder and CEO of Mammoth Biosciences on Fortune’s 2019 40 Under 40
Trevor Martin Courtesy of Molly Jorgensen - Mammoth Biosciences Mammoth Biosciences [...]
An early taste of Wild Type Salmon
Wild Type’s lab-grown salmon product. Source: Wild Type Inc. Read original article [...]
ViewPoint
ViewPoint develops a nonsurgical route to cataract treatment.
MBC BioLab’s first company, Alector, is getting ready to go public
Alector moved into MBC BioLabs on the day we opened our doors, and now just over fi [...]
Cypre and Molecular Devices sign co-marketing agreement to collaborate on delivering solutions for screening biologically relevant assays
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cy [...]
Peninsula Alzheimer’s fighter hunts $150 million IPO
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS T [...]
Prellis Biologics and CELLINK Sign Partnership
Prellis Biologics and CELLINK Sign Partnership Prellis Biologics and CELLINK sign pa [...]
Mammoth Biosciences Featured on Forbes 30 Under 30
Mammoth Biosciences Featured on Forbes 30 Under 30 Congratulations to Trevor Martin, [...]
Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine
After completing their graduate work at Stanford, Trevor Martin and Ashley Tehranchi took [...]
MBC BioLabs’ new San Carlos site has now welcomed fourteen companies
We launched the first phase of our new campus in San Carlos on May 1, and we have now on- [...]